What is AARD's return on equity?

AARD (AARD) reported return on equity of -58.8% in Q1 2026.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

AARD AARD Return on equity

Return on equity at other companies

AbbVieABBV

89%+32.7pp

Relmada Therapeutics, Inc.RLMD

-48.8%-20.0pp

Rhythm Pharmaceuticals, Inc.RYTM

-285.8%-68.9pp

Viking TherapeuticsVKTX

-70%-94.5pp

ArvinasARVN

-42.3%-53.5pp

Protagonist TherapeuticsPTGX

-17.1%-26.1pp

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

net income/total stockholders equity=-58.8%

Based on trailing twelve months.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's return on equity?: AARD (AARD) reported return on equity of -58.8% in Q1 2026.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.